NASDAQ · TMDX
TransMedics Group, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for TMDX: Nov 05, 2026
TransMedics Group, Inc. Common Stock is expected to report earnings on 11/05/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 5 analysts' forecasts, the consensus EPS forecast for the quarter is $0.27. The reported EPS for the same quarter last year was $0.66.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.27 | $0.35 | $0.15 | 5 |
| Dec 2026 | $0.42 | $0.53 | $0.31 | 6 |
| Mar 2027 | $0.53 | $0.59 | $0.50 | 3 |
| Jun 2027 | $0.60 | $0.67 | $0.55 | 3 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
BNK Invest · The Motley Fool · RTTNews · Zacks- BNK Invest · Oct 16, 3:54 PM EDTNoteworthy Friday Option Activity: HOOD, TMDX, AAAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Robinhood Markets Inc (Symbol: HOOD), where a total of 387,037 contracts have traded so far, representing approximately 38.7 million underlying shares. That amounts to a
- The Motley Fool · Sep 29, 12:37 PM EDTTransMedics Director David Weill Purchases $109,000 of Stock — Should Investors Buy Too?The director acquired 1,336 shares for a total value of ~$109,000 on Sept. 11, 2026.
- The Motley Fool · Sep 15, 10:20 AM EDT2 Stocks Down 28% and 34% to Buy and HoldTransMedics Group's investments are currently lowering margins, but they could eventually boost revenue and profits.
- RTTNews · Sep 10, 4:33 PM EDTTransmedics Names Fernando Araujo CFO, Reiterates FY26 Outlook(RTTNews) – On Thursday, TransMedics Group, Inc. (TMDX), a portable warm perfusion provider, announced that it has appointed Fernando Araujo as Chief Financial Officer, effective September 21. Additionally, TransMedics is reiterating its full-year revenue guidance for 2026.
- Zacks · Sep 3, 2:00 PM EDTIs TMDX Stock Worth Buying as Growth Meets Rising Margin Pressure?TransMedics' rapid revenue growth and cheaper valuation face rising margin pressure as heavy investment raises execution risks.
- Zacks · Sep 3, 11:30 AM EDTWhy Is TransMedics (TMDX) Up 10.2% Since Last Earnings Report?TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- BNK Invest · Aug 24, 7:07 AM EDTTransMedics Group Reaches Analyst Target PriceIn recent trading, shares of TransMedics Group Inc (Symbol: TMDX) have crossed above the average analyst 12-month target price of $94.36, changing hands for $94.77/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade o
- BNK Invest · Aug 18, 5:33 PM EDTNoteworthy Tuesday Option Activity: BOC, TMDX, MPCAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Boston Omaha Corp (Symbol: BOC), where a total of 1,872 contracts have traded so far, representing approximately 187,200 underlying shares. That amounts to about 180.8%
- MarketBeat · Aug 18, 1:01 AM EDTTransMedics Targets $2B Opportunity With Kidney Push, European ExpansionMid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in MayTransMedics Group (NASDAQ:TMDX) outlined its growth strategy at Canaccord Genuity’s 46th Annual Global Growth Conference, highlighting investments in kidney transplantation, European expansion, next-generation technolog
- The Motley Fool · Aug 11, 7:43 PM EDTTransMedics (TMDX) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Aug 5, 1:42 PM EDTTransMedics Stock Dips Post Q2 Earnings Miss, Margins ContractTMDX's Q2 revenue beat and raised outlook are overshadowed by earnings miss, declining margins and sharply higher operating costs.
- The Motley Fool · Aug 5, 1:37 PM EDTWhy TransMedics Stock Is Sinking TodayTransMedics grew sales by 21%, but adjusted net income was more than halved as the company reinvested in its growth.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for TransMedics Group, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.